PIMJS
DGX icon

PKO Investment Management Joint-Stock’s Quest Diagnostics DGX Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$212K Hold
1,000
– – 0.02% 224
2026
Q1 		$196K Sell
1,000
-500
-33% -$97.1K 0.02% 211
2025
Q4 		$260K Hold
1,500
– – 0.02% 207
2025
Q3 		$286K Buy
+1,500
New +$266K 0.02% 192

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

PKO Investment Management Joint-Stock's DGX Position: Q2 2026 in Review

PKO Investment Management Joint-Stock held its Quest Diagnostics (DGX) position steady in Q2 2026 at 1,000 shares worth $212K. The position accounts for 0.02% of the portfolio, ranked #224.

PKO Investment Management Joint-Stock first reported a position in DGX in Q3 2025 and has held it in 4 quarters since. The position peaked at $286K in Q3 2025. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • PKO Investment Management Joint-Stock held 1,000 shares of Quest Diagnostics worth $212K as of Q2 2026.
  • PKO Investment Management Joint-Stock left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up 0.02% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #224 holding.
  • PKO Investment Management Joint-Stock first reported a position in Quest Diagnostics in Q3 2025 and has held it in 4 quarters since.
  • PKO Investment Management Joint-Stock's Quest Diagnostics position peaked at $286K in Q3 2025.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.